Prevalence of vitiligo and associated comorbidities in Korea

Hemin Lee, Mu Hyoung Lee, Dong Youn Lee, Hee Young Kang, Ki Ho Kim, Gwang Seong Choi, Jeonghyun Shin, Hee Jung Lee, Dong Hyun Kim, Tae Heung Kim, Ai Young Lee, Seung Chul Lee, Sanghoon Lee, Kyoung Wan Kim, Seung Kyung Hann, Chul Jong Park, Sang Ho Oh

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Purpose: Vitiligo prevalence and its associated comorbidities rate have been reported variably among different populations. We aimed to determine the prevalence of vitiligo in Korea along with the baseline rate of comorbidities and compared the risks to the general population using hospital visit information of the total population in Korea. Materials and Methods: We assessed demographic characteristics of vitiligo patients in Korean population from 2009 to 2011 in a nationwide data from Health Insurance Review Assessment Service. Patients who had at least one visit to Korea’s primary, secondary, or tertiary referral hospitals with International Classification of Diseases, 10th Revision, Clinical Modification diagnosis code for vitiligo were identified. As a supplementary study, comorbidities associated with vitiligo were selected for further review to calculate relative risks compared to the general population. Results: The annual prevalence of vitiligo determined by hospital-visiting rate in Korea was 0.12% to 0.13% over a three year period. In sync with other previous epidemiological studies, there was bimodal distribution among the age groups and no difference between genders. Also, vitiligo in Korean population was associated with various autoimmune/non-autoimmune diseases such as thyroiditis, atopic dermatitis, and psoriasis. Conclusion: This study was by far the most comprehensive review on prevalence of vitiligo using a data of total population in Korea. The prevalence is within a range of those reported in previous literatures, and increased risk of comorbidities such as thyroid diseases and psoriasis in vitiligo might aid clinicians in the initial work up of vitiligo patients and concurrent follow ups.

Original languageEnglish
Pages (from-to)719-725
Number of pages7
JournalYonsei medical journal
Volume56
Issue number3
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Vitiligo
Korea
Comorbidity
Population
Psoriasis
Secondary Care Centers
Thyroiditis
Thyroid Diseases
International Classification of Diseases
Atopic Dermatitis
Health Insurance
Tertiary Care Centers
Epidemiologic Studies
Age Groups
Demography

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Lee, H., Lee, M. H., Lee, D. Y., Kang, H. Y., Kim, K. H., Choi, G. S., ... Oh, S. H. (2015). Prevalence of vitiligo and associated comorbidities in Korea. Yonsei medical journal, 56(3), 719-725. https://doi.org/10.3349/ymj.2015.56.3.719
Lee, Hemin ; Lee, Mu Hyoung ; Lee, Dong Youn ; Kang, Hee Young ; Kim, Ki Ho ; Choi, Gwang Seong ; Shin, Jeonghyun ; Lee, Hee Jung ; Kim, Dong Hyun ; Kim, Tae Heung ; Lee, Ai Young ; Lee, Seung Chul ; Lee, Sanghoon ; Kim, Kyoung Wan ; Hann, Seung Kyung ; Park, Chul Jong ; Oh, Sang Ho. / Prevalence of vitiligo and associated comorbidities in Korea. In: Yonsei medical journal. 2015 ; Vol. 56, No. 3. pp. 719-725.
@article{8c1ac2d148834fd3ba0682a583996261,
title = "Prevalence of vitiligo and associated comorbidities in Korea",
abstract = "Purpose: Vitiligo prevalence and its associated comorbidities rate have been reported variably among different populations. We aimed to determine the prevalence of vitiligo in Korea along with the baseline rate of comorbidities and compared the risks to the general population using hospital visit information of the total population in Korea. Materials and Methods: We assessed demographic characteristics of vitiligo patients in Korean population from 2009 to 2011 in a nationwide data from Health Insurance Review Assessment Service. Patients who had at least one visit to Korea’s primary, secondary, or tertiary referral hospitals with International Classification of Diseases, 10th Revision, Clinical Modification diagnosis code for vitiligo were identified. As a supplementary study, comorbidities associated with vitiligo were selected for further review to calculate relative risks compared to the general population. Results: The annual prevalence of vitiligo determined by hospital-visiting rate in Korea was 0.12{\%} to 0.13{\%} over a three year period. In sync with other previous epidemiological studies, there was bimodal distribution among the age groups and no difference between genders. Also, vitiligo in Korean population was associated with various autoimmune/non-autoimmune diseases such as thyroiditis, atopic dermatitis, and psoriasis. Conclusion: This study was by far the most comprehensive review on prevalence of vitiligo using a data of total population in Korea. The prevalence is within a range of those reported in previous literatures, and increased risk of comorbidities such as thyroid diseases and psoriasis in vitiligo might aid clinicians in the initial work up of vitiligo patients and concurrent follow ups.",
author = "Hemin Lee and Lee, {Mu Hyoung} and Lee, {Dong Youn} and Kang, {Hee Young} and Kim, {Ki Ho} and Choi, {Gwang Seong} and Jeonghyun Shin and Lee, {Hee Jung} and Kim, {Dong Hyun} and Kim, {Tae Heung} and Lee, {Ai Young} and Lee, {Seung Chul} and Sanghoon Lee and Kim, {Kyoung Wan} and Hann, {Seung Kyung} and Park, {Chul Jong} and Oh, {Sang Ho}",
year = "2015",
month = "1",
day = "1",
doi = "10.3349/ymj.2015.56.3.719",
language = "English",
volume = "56",
pages = "719--725",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "3",

}

Lee, H, Lee, MH, Lee, DY, Kang, HY, Kim, KH, Choi, GS, Shin, J, Lee, HJ, Kim, DH, Kim, TH, Lee, AY, Lee, SC, Lee, S, Kim, KW, Hann, SK, Park, CJ & Oh, SH 2015, 'Prevalence of vitiligo and associated comorbidities in Korea', Yonsei medical journal, vol. 56, no. 3, pp. 719-725. https://doi.org/10.3349/ymj.2015.56.3.719

Prevalence of vitiligo and associated comorbidities in Korea. / Lee, Hemin; Lee, Mu Hyoung; Lee, Dong Youn; Kang, Hee Young; Kim, Ki Ho; Choi, Gwang Seong; Shin, Jeonghyun; Lee, Hee Jung; Kim, Dong Hyun; Kim, Tae Heung; Lee, Ai Young; Lee, Seung Chul; Lee, Sanghoon; Kim, Kyoung Wan; Hann, Seung Kyung; Park, Chul Jong; Oh, Sang Ho.

In: Yonsei medical journal, Vol. 56, No. 3, 01.01.2015, p. 719-725.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prevalence of vitiligo and associated comorbidities in Korea

AU - Lee, Hemin

AU - Lee, Mu Hyoung

AU - Lee, Dong Youn

AU - Kang, Hee Young

AU - Kim, Ki Ho

AU - Choi, Gwang Seong

AU - Shin, Jeonghyun

AU - Lee, Hee Jung

AU - Kim, Dong Hyun

AU - Kim, Tae Heung

AU - Lee, Ai Young

AU - Lee, Seung Chul

AU - Lee, Sanghoon

AU - Kim, Kyoung Wan

AU - Hann, Seung Kyung

AU - Park, Chul Jong

AU - Oh, Sang Ho

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Purpose: Vitiligo prevalence and its associated comorbidities rate have been reported variably among different populations. We aimed to determine the prevalence of vitiligo in Korea along with the baseline rate of comorbidities and compared the risks to the general population using hospital visit information of the total population in Korea. Materials and Methods: We assessed demographic characteristics of vitiligo patients in Korean population from 2009 to 2011 in a nationwide data from Health Insurance Review Assessment Service. Patients who had at least one visit to Korea’s primary, secondary, or tertiary referral hospitals with International Classification of Diseases, 10th Revision, Clinical Modification diagnosis code for vitiligo were identified. As a supplementary study, comorbidities associated with vitiligo were selected for further review to calculate relative risks compared to the general population. Results: The annual prevalence of vitiligo determined by hospital-visiting rate in Korea was 0.12% to 0.13% over a three year period. In sync with other previous epidemiological studies, there was bimodal distribution among the age groups and no difference between genders. Also, vitiligo in Korean population was associated with various autoimmune/non-autoimmune diseases such as thyroiditis, atopic dermatitis, and psoriasis. Conclusion: This study was by far the most comprehensive review on prevalence of vitiligo using a data of total population in Korea. The prevalence is within a range of those reported in previous literatures, and increased risk of comorbidities such as thyroid diseases and psoriasis in vitiligo might aid clinicians in the initial work up of vitiligo patients and concurrent follow ups.

AB - Purpose: Vitiligo prevalence and its associated comorbidities rate have been reported variably among different populations. We aimed to determine the prevalence of vitiligo in Korea along with the baseline rate of comorbidities and compared the risks to the general population using hospital visit information of the total population in Korea. Materials and Methods: We assessed demographic characteristics of vitiligo patients in Korean population from 2009 to 2011 in a nationwide data from Health Insurance Review Assessment Service. Patients who had at least one visit to Korea’s primary, secondary, or tertiary referral hospitals with International Classification of Diseases, 10th Revision, Clinical Modification diagnosis code for vitiligo were identified. As a supplementary study, comorbidities associated with vitiligo were selected for further review to calculate relative risks compared to the general population. Results: The annual prevalence of vitiligo determined by hospital-visiting rate in Korea was 0.12% to 0.13% over a three year period. In sync with other previous epidemiological studies, there was bimodal distribution among the age groups and no difference between genders. Also, vitiligo in Korean population was associated with various autoimmune/non-autoimmune diseases such as thyroiditis, atopic dermatitis, and psoriasis. Conclusion: This study was by far the most comprehensive review on prevalence of vitiligo using a data of total population in Korea. The prevalence is within a range of those reported in previous literatures, and increased risk of comorbidities such as thyroid diseases and psoriasis in vitiligo might aid clinicians in the initial work up of vitiligo patients and concurrent follow ups.

UR - http://www.scopus.com/inward/record.url?scp=84926376086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926376086&partnerID=8YFLogxK

U2 - 10.3349/ymj.2015.56.3.719

DO - 10.3349/ymj.2015.56.3.719

M3 - Article

C2 - 25837178

AN - SCOPUS:84926376086

VL - 56

SP - 719

EP - 725

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 3

ER -

Lee H, Lee MH, Lee DY, Kang HY, Kim KH, Choi GS et al. Prevalence of vitiligo and associated comorbidities in Korea. Yonsei medical journal. 2015 Jan 1;56(3):719-725. https://doi.org/10.3349/ymj.2015.56.3.719